Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study-Reference-Cited by-同舟云学术

Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study

Published:2018-06 Issue:6 Volume:5 Page:e291-e300
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Ryom Lene,Lundgren Jens D,El-Sadr Wafaa,Reiss Peter,Kirk Ole,Law Matthew,Phillips Andrew,Weber Rainer,Fontas Eric,d' Arminio Monforte Antonella,De Wit Stéphane,Dabis Francois,Hatleberg Camilla I,Sabin Caroline,Mocroft Amanda

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference27 articles.

1. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study;Schouten;Clin Infect Dis,2014

2. An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: the data-collection on adverse effects of anti-HIV drugs (D:A:D) study;Friis-Møller;Eur J Prev Cardiol,2016

3. Combination antiretroviral therapy and the risk of myocardial infarction;Friis-Møller;N Engl J Med,2003

4. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men;Mary-Krause;AIDS,2003

5. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction;Stein;Circulation,2001

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomised control trial of BIC/F/TAF vs DRV/c/F/TAF in context of HIV test-and-treat, BicTnT;HIV Research & Clinical Practice;2024-09-08

2. Atherosclerosis and Cardiovascular Complications in People Living with HIV: A Focused Review;Infectious Disease Reports;2024-09-01

3. Cardiovascular disease risk in people of African ancestry with HIV in the United Kingdom;HIV Medicine;2024-08-29

4. Evaluation of infectious diseases physicians’ attitudes to dyslipidemia management in PLWH;Postgraduate Medicine;2024-08-22

5. Role of the pharmacist caring for people at risk of or living with HIV in Canada;Canadian Pharmacists Journal / Revue des Pharmaciens du Canada;2024-08-02